University of Kentucky (172) — Lexington, Kentucky

University of Kentucky (172) is a clinical research site located in Lexington, Kentucky, United States 40536.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Kentucky (172) has participated in 1 clinical trials.

Therapeutic areas: Early Parkinson Disease.

Sponsors: Neurogen Corporation.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Kentucky (172)?

University of Kentucky (172) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Kentucky (172) conducted?

University of Kentucky (172) has 1 clinical trials on record. Their work covers Early Parkinson Disease.

Is University of Kentucky (172) accredited by Crixeo Health?

University of Kentucky (172) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Kentucky (172)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.